Israeli researchers have found that a COVID-19 protein, NP, may cause the immune system to attack healthy cells, possibly explaining severe or long COVID cases. The study, published in Cell Reports, shows that the drug enoxaparin can block this effect, offering hope for new treatments against immune-related COVID complications.